Tech Company Financing Transactions
Pearl Therapeutics Funding Round
Pearl Therapeutics, based in Redwood City, raised $500 thousand in funding from 5AM Ventures.
Transaction Overview
Company Name
Announced On
6/30/2014
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
5AM Ventures (James Young)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
200 Saginaw Drive
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Pearl Therapeutics is focused on developing a pipeline of novel andsuperior products for chronic respiratory disorders, providing patientswith advanced therapeutic options in familiar and well accepted dosageforms. The company has licensed advanced particle technology from NektarTherapeutics (Nasdaq: NKTR) for developing a series of products in selectedtherapeutic fields.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Bramlage
Chief Medical Officer
Colin Reisner
Chief Scientific Officer
Sarvajna Dwivedi
VP - Bus. Development
Lyn Baranowski
VP - Finance
William Picht
VP - Product Management
Robert Schultz
VP - Regulatory Affairs
Michael Golden
Browse more venture capital transactions:
Prev: 6/30/2014: US HealthVest venture capital transaction
Next: 6/30/2014: TRGRP venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs